Pulmonx Corporation (LUNG) Live Share Price, Invest From India

Pulmonx Corporation Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.25
Day's Price Range
$1.32
$1.28
2.34%
Downside
3.13%
Upside
52 Week's Low
52 Week's High
$1.13
52-Week Price Range
$3.88
$1.28
11.72%
Downside
203.12%
Upside

Pulmonx Corporation share price movements today

Previous Close: $1.25
Open: $1.27
Volume: 1.1M
Day's Low - High: $1.25 - $1.32
52 Week Low - High: $1.13 - $3.88

Pulmonx Corporation Historical Returns

1 Month Return: -4.48 %
3 Month Return: -7.91 %
1 Year Return: -53.45 %
3 Year Return: -89.86 %
5 Year Return: -96.97 %

Pulmonx Corporation Stock Fundamentals & Key Indicators

Check Pulmonx Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.8M

EPS (TTM)

-1.142

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-51.2M

Revenue (TTM)

88.5M

Profit Margin

-60.09%

Return On Equity TTM

-86.22%

Pulmonx Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmonx Corporation with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Pulmonx Corporation	BUY	$52.8M	-96.97%	NA	-60.09%	NA
Stryker Corporation	BUY	$115.4B	20.75%	34.89	13.21%	1.11%
Edwards Lifesciences Corp	BUY	$49.9B	-13.26%	46.85	17.39%	NA
Medtronic plc	BUY	$100.3B	-35.62%	20.73	13.20%	3.49%
Boston Scientific Corp.	BUY	$66.8B	5.28%	18.81	17.29%	NA

See all

Stock Returns calculator for Pulmonx Corporation Stock including INR - Dollar returns

The Pulmonx Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Pulmonx Corporation investment value today

Current value as on today

₹50,549

Returns

-₹49,451

(-49.45%)

Returns from Pulmonx Corporation Stock

-₹53,455 (-53.45%)

Dollar Impact

₹4,004 (+4%)

Analyst Recommendation on Pulmonx Corporation Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Pulmonx Corporation. Average target price of $3.4

Pulmonx Corporation Share Price Target

Get share price movements and forecasts by analysts on Pulmonx Corporation.

What analysts predicted

62.35%UPSIDE

Target Price

$3.4

Current Price

$1.28

Analyzed by

11 Analysts

Target

$3.40

Pulmonx Corporation target price $3.4, a slight upside of 62.35% compared to current price of $1.28. According to 11 analysts rating.

Indian Investors' Interest in Pulmonx Corporation Stock

Search interest for Pulmonx Corporation Stock has increased by 222% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:222% versus previous 30 day period

Pulmonx Corporation Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	19	18	20	20	23	22	23	21	22	20
Gross Profit	14	13	15	15	17	16	17	16	17	16
Operating Income	-13	-14	-15	-14	-13	-14	-14	-14	-9	-12
EBITDA	-12	-12	-13	-12	-12	-14	-13	-12	-9	-12
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-13	-13	-15	-13	-13	-14	-14	-13	-10	-13
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-13	-13	-15	-14	-13	-14	-15	-13	-10	-13
Net Profit Margin	-72.04%	-72.92%	-73.74%	-69.38%	-55.44%	-64.11%	-63.59%	-64.91%	-46.13%	-66.33%

Pulmonx Corporation Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	-	20	32	32	48	53	68	83	90
Gross Profit	0	-	12	22	21	35	39	50	62	67
Operating Income	-2	-5	-15	-17	-32	-47	-58	-61	-57	-53
EBITDA	-	-	-15	-16	-28	-46	-55	-55	-50	-49
Interest Expense	-	-	2	2	3	0	1	3	3	3
Depreciation	-	-	0	0	0	0	1	1	1	1
Income Before Tax	-2	-5	-18	-20	-32	-48	-58	-60	-55	-53
Income Tax Expense	-	-	0	0	0	0	0	0	0	0
Net Income	-2	-5	-18	-20	-32	-48	-58	-60	-56	-54
Net Profit Margin	-31539.27%	0.00%	-92.38%	-63.52%	-98.47%	-100.51%	-109.80%	-88.60%	-67.30%	-59.67%

Pulmonx Corporation Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-15	-14	-13	-14	-15	-13	-10	-13
Operating Cash Flow	-11	-5	-7	-6	-13	-3	-8	-7	-10
Investing Cash Flow	-2	0	6	14	16	5	8	0	0
Financing Cash Flow	0	0	0	0	0	0	0	0	2
Change in Cash	-13	-6	0	7	3	0	1	-6	-8

Pulmonx Corporation Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-18	-20	-32	-48	-58	-60	-56	-54
Operating Cash Flow	-4	-18	-20	-30	-41	-45	-37	-31	-32
Investing Cash Flow	0	0	-14	12	-46	-4	-2	17	30
Financing Cash Flow	5	12	45	234	4	2	21	1	0
Change in Cash	0	-5	10	217	-83	-46	-18	-12	-1

Global Institutional Holdings in Pulmonx Corporation

Funds	Holdings
Morgan Stanley - Brokerage Accounts	9.46%
Dimensional Fund Advisors, Inc.	1.12%
Renaissance Technologies Corp	0.76%
Soleus Capital Management, L.P.	6.6%
Bank of America Corp	2.76%

See all

Insights on Pulmonx Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 18.3% return, outperforming this stock by 69.4%
NO EFFECT
Against Peers
In the last 3 years, Pulmonx Corporation Common Stock has experienced a drawdown of -90.6%, however Stryker Corporation resisted the overall trend and outperformed by 85.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -10.42M → -13.65M (in $), with an average decrease of 31.0% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 22.59M → 20.58M (in $), with an average decrease of 8.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 6 months, LUNG stock has moved down by -50.8%

About Pulmonx Corporation

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Organisation	Pulmonx Corporation
Headquarters	700 Chesapeake Drive, Redwood City, CA, United States, 94063
Industry	Medical Devices
CEO	Mr. Glendon E. French
E-voting on shares	Click here to vote

Key Management of Pulmonx Corporation

Name	Title
Ms. Lisa Paul	Chief People Officer
Mr. Geoffrey Beran Rose	Chief Commercial Officer
Dr. Narinder S. Shargill Ph.D.	Senior Vice President of Global Medical & Clinical Affairs
Mr. John B. McKune	VP of Finance & Corporate Controller
Mr. David A. Lehman J.D.	General Counsel & Secretary
Dr. Derrick Sung Ph.D.	CFO & COO
Mr. Srikanth Radhakrishnan	Chief Science & Technology Officer
Ms. Marcee M. Maroney	Vice President of Marketing
Mr. Jérôme Erath	Senior VP & GM of International
Mr. Glendon E. French	CEO, President & Director

FAQs

What is Pulmonx Corporation share price today?

Pulmonx Corporation share price today is $1.28 as on June 19, 2026 at 8:45 am IST at the close of the market. Pulmonx Corporation share today touched a day high of $1.32 and a low of $1.25.

What is the 52 week high and 52 week low for Pulmonx Corporation share?

Pulmonx Corporation share touched a 52 week high of $3.88 on July 23, 2025 and a 52 week low of $1.13 on March 30, 2026. Pulmonx Corporation stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $1.28,which is 67.01% down from its 52 week high and 13.27% up from its 52 week low.

What is Pulmonx Corporation's market capitalisation today?

Pulmonx Corporation market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Pulmonx Corporation Stock (LUNG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pulmonx Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Corporation Shares that will get you 1.1719 shares as per Pulmonx Corporation share price of $1.28 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pulmonx Corporation Stock (LUNG) from India?

Indian investors can start investing in Pulmonx Corporation (LUNG) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 8:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Pulmonx Corporation stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 8:43 pm IST). Based on Pulmonx Corporation share’s latest price of $1.28 as on June 19, 2026 at 8:45 am IST, you will get 7.8125 shares of Pulmonx Corporation. Learn more about fractional shares .

What are the returns that Pulmonx Corporation has given to Indian investors in the last 5 years?

Pulmonx Corporation stock has given -96.97% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?